Dáil Éireann Debate, Tuesday - 19 May 2026
1049. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or risk assessment has been conducted examining the patient safety implications of rejected pharmacy claims under the PCRS system in the past five years. [36798/26]
View answerUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
